Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06128200 · ClinicalTrials.gov registry record · NA
NEUROMARK Randomized Controlled Trial
A NA study, sponsored by Neurent Medical.
- Completed
- Registry status
- NA
- Development phase
- 132
- Enrollment target
NCT06128200 is a NA study that has completed, run by Neurent Medical. The registered enrollment target is 132 participants.
The verdict
NCT06128200, a NA study, has completed, sponsored by Neurent Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 132 participants
- Enrollment target
Study Summary
The NEUROMARK RCT Study is a prospective, multicenter, randomized, sham-controlled, single-blinded, superiority trial.
Interventions
- DEVICE NEUROMARK System
- DEVICE Sham NEUROMARK System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2023-10-10 |
| Est. Completion | 2025-11-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06128200
The ClinicalTrials.gov registry entry for NCT06128200 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neurent Medical, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NEUROMARK System is the first listed.
NCT06128200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06128200 about?
NCT06128200 is a clinical study titled "NEUROMARK Randomized Controlled Trial". The NEUROMARK RCT Study is a prospective, multicenter, randomized, sham-controlled, single-blinded, superiority trial.
What is the current status of trial NCT06128200?
This trial is currently completed. It is a NA study. The enrollment target is 132 participants. The study started on 2023-10-10. Estimated completion is 2025-11-26.
What interventions are being tested in trial NCT06128200?
The interventions under investigation include: NEUROMARK System (DEVICE), Sham NEUROMARK System (DEVICE).
Who is sponsoring clinical trial NCT06128200?
This trial is sponsored by Neurent Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.